#BEGIN_DRUGCARD DB01852

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
520-18-3

# ChEBI_ID:
28499

# Chemical_Formula:
C15H10O6

# Chemical_IUPAC_Name:
3,5,7-trihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Kaempherol

# HET_ID:
KMP

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C15H10O6/c16-8-3-1-7(2-4-8)15-14(20)13(19)12-10(18)5-9(17)6-11(12)21-15/h1-6,16-18,20H

# InChI_Key:
InChIKey=IYRMWMYZSQPJKC-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C05903

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1852

# Mechanism_Of_Action:
Not Available

# Melting_Point:
277 Â°C

# Molecular_Weight_Avg:
286.2363

# Molecular_Weight_Mono:
286.047738052

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1H1M

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
1.99

# Predicted_LogS:
-3.2

# Predicted_Water_Solubility:
1.78e-01 g/l

# Primary_Accession_No:
DB01852

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
5280863

# PubChem_Substance_ID:
46507811

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01976

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC1=CC=C(C=C1)C1=C(O)C(=O)C2=C(O1)C=C(O)C=C2O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:33 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Membrane

# Drug_Target_1_Chromosome_Location:
5

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AK057066

# Drug_Target_1_GenBank_ID_Protein:
16552644

# Drug_Target_1_GeneCard_ID:
UGT3A1

# Drug_Target_1_Gene_Name:
UGT3A1

# Drug_Target_1_Gene_Sequence:
>1572 bp
ATGGTTGGGCAGCGGGTGCTGCTTCTAGTGGCCTTCCTTCTTTCTGGGGTCCTGCTCTCA
GAGGCTGCCAAAATCCTGACAATATCTACACTGGGTGGAAGCCATTACCTACTGTTGGAC
CGGGTGTCTCAGATTCTTCAAGAGCATGGTCATAATGTGACTATGCTTCATCAGAGTGGA
AAGTTTTTGATCCCAGATATTAAAGAGGAGGAAAAATCATACCAAGTTATCAGGTGGTTT
TCACCTGAAGATCATCAAAAAAGAATTAAGAAGCATTTTGATAGCTACATAGAAACAGCA
TTGGATGGCAGAAAAGAATCTGAAGCCCTTGTAAAGCTAATGGAAATATTTGGGACTCAA
TGTAGTTATTTGCTAAGCAGAAAGGATATAATGGATTCCTTAAAGAATGAGAACTGTGAT
CTGGTATTTGTTGAAGCATTTGATTTCTGTTCTTTCCTGATTGCTGAGAAGCTTGTGAAA
CCATTTGTGGCCATTCTTCCCACCACATTCGGCTCTTTGGATTTTGGGCTACCAAGCCCC
TTGTCTTATGTTCCAGTATTCCCTTCCTTGCTGACTGATCACATGGACTTCTGGGGCCGA
GTGAAGAATTTTCTGATGTTCTTTAGTTTCTCCAGGAGCCAATGGGACATGCAGTCTACA
TTTGACAACACCATCAAGGAGCATTTCCCAGAAGGCTCTAGGCCAGTTTTGTCTCATCTT
CTACTGAAAGCAGAGTTGTGGTTTGTTAACTCTGATTTTGCCTTTGATTTTGCCCGGCCC
CTGCTTCCCAACACTGTTTATATTGGAGGCTTGATGGAAAAACCTATTAAACCAGTACCA
CAAGACTTGGACAACTTCATTGCCAACTTTGGGGATGCAGGGTTTGTCCTTGTGGCCTTT
GGCTCCATGTTGAACACCCATCAGTCCCAGGAAGTCCTCAAGAAGATGCACAATGCCTTT
GCCCACCTCCCTCAAGGAGTGATATGGACATGTCAGAGTTCTCATTGGCCCAGAGATGTT
CATTTGGCCACAAATGTGAAAATTGTGGACTGGCTTCCTCAGAGTGACCTCCTGGCTCAC
CCCAGCATCCGTCTTTTTGTCACTCATGGTGGGCAGAACAGCGTAATGGAGACCATCCGT
CATGGTGTGCCCATGGTGGGATTACCAGTCAATGGAGACCAGCATGGAAACATGGTCCGA
GTAGTAGCCAAAAATTATGGTGTCTCTATCCGGTTGAATCAGGTCACAGCCGACACACTG
ACACTTACAATGAAACAAGTCATAGAAGACAAGAGGTACAAGTCGGCAGTGGTGGCAGCC
AGTGTCATCCTGCACTCTCAGCCCCTGAGCCCCGCACAGCGGCTGGTGGGCTGGATCGAC
CACATCCTCCAGACTGGGGGAGCGACGCACCTCAAGCCCTATGTCTTCCAGCAGCCTTGG
CATGAGCAGTACCTCATTGATGTCTTTGTGTTTCTGCTGGGGCTCACTCTGGGCACTATG
TGGCTTTGTGGGAAGCTGCTGGGTGTGGTGGCCAGGTGGCTGCGTGGGGCCAGGAAGGTG
AAGAAGACATGA

# Drug_Target_1_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_1_General_References:
14702039	Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21.
15489334	Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.

# Drug_Target_1_HGNC_ID:
GNC:26625

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
6656

# Drug_Target_1_Locus:
5p13.2

# Drug_Target_1_Molecular_Weight:
59150.3

# Drug_Target_1_Name:
UDP-glucuronosyltransferase 3A1

# Drug_Target_1_Number_of_Residues:
523

# Drug_Target_1_PDB_ID:
Not Available

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00201	UDPGT

# Drug_Target_1_Protein_Sequence:
>UDP-glucuronosyltransferase 3A1
MVGQRVLLLVAFLLSGVLLSEAAKILTISTLGGSHYLLLDRVSQILQEHGHNVTMLHQSG
KFLIPDIKEEEKSYQVIRWFSPEDHQKRIKKHFDSYIETALDGRKESEALVKLMEIFGTQ
CSYLLSRKDIMDSLKNENYDLVFVEAFDFCSFLIAEKLVKPFVAILPTTFGSLDFGLPSP
LSYVPVFPSLLTDHMDFWGRVKNFLMFFSFSRSQWDMQSTFDNTIKEHFPEGSRPVLSHL
LLKAELWFVNSDFAFDFARPLLPNTVYIGGLMEKPIKPVPQDLDNFIANFGDAGFVLVAF
GSMLNTHQSQEVLKKMHNAFAHLPQGVIWTCQSSHWPRDVHLATNVKIVDWLPQSDLLAH
PSIRLFVTHGGQNSVMEAIRHGVPMVGLPVNGDQHGNMVRVVAKNYGVSIRLNQVTADTL
TLTMKQVIEDKRYKSAVVAASVILHSQPLSPAQRLVGWIDHILQTGGATHLKPYAFQQPW
HEQYLIDVFVFLLGLTLGTMWLCGKLLGVVARWLRGARKVKKT

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
1-22

# Drug_Target_1_Specific_Function:
UDP-glucuronosyltransferases catalyze phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase water solubility and enhance excretion. They are of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds (By similarity)

# Drug_Target_1_SwissProt_ID:
Q6NUS8

# Drug_Target_1_SwissProt_Name:
UD3A1_HUMAN

# Drug_Target_1_Synonyms:
UDPGT 3A1

# Drug_Target_1_Theoretical_pI:
8.35

# Drug_Target_1_Transmembrane_Regions:
484-504

#END_DRUGCARD DB01852
